People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Other Technology, Biotechnology, Healthtech, Other, Manufacturing
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| 2U, Inc. | — | Other Technology | Series D+ | $410.2M | $10.2B | 2009 |
| Miromatrix Medical Inc. | — | Biotechnology | Series B | $44.8M | $623.9M | 2011 |
| Appriss Health Holdings, Inc. | — | Healthtech | Series B | $38.1M | $717.4M | 2021 |
| Artists Writers & Artisans, Inc. | — | Other | Series B | $31.6M | $36.6M | 2021 |
| Aktivate, Inc. | — | Other Technology | Series A | $17.2M | $5.7M | 2023 |
| Highwing, Inc. | — | Other Technology | Series A | $13.3M | $47.0M | 2020 |
| KidzToPros, Inc. | — | Other | Series A | $12.9M | $23.1M | 2023 |
| Grandparents.Com, Inc. | — | Other | Seed | $7.7M | $18.6M | 2015 |
| EmboMedics, Inc. | — | Biotechnology | Series A | $5.9M | $26.8M | 2016 |
| UmaChaka Media, Inc. | — | Other | Pre-Seed | $540K | $12.5M | 2012 |
| 2Dye4 Anodizing Inc | — | Manufacturing | Pre-Seed | $105K | $1.6M | 2009 |
Robert Cohen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert Cohen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Chernis | 2 | 4 |
| Anika Agarwal | 1 | 13 |
| GREG MARTIN | 1 | 12 |
| Rob Stavis | 1 | 11 |
| Paul Buckman | 1 | 10 |
| Scott Barclay | 1 | 8 |
| Jonathan Miller | 1 | 8 |
| JON MILLER | 1 | 8 |
| Matthew Anderson | 1 | 7 |
| James Pade | 1 | 6 |
| Avi Naider | 1 | 6 |
| Krishnan Sastry | 1 | 5 |
| Timothy J. Flynn | 1 | 5 |
| Jon Freeman | 1 | 5 |
| Jeffrey Ross | 1 | 5 |
| John Katzman | 1 | 5 |
| Behdad Eghbali | 1 | 5 |
| Philip Bronner | 1 | 5 |
| Jason Palmer | 1 | 5 |
| Arrun Kapoor | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.